181 related articles for article (PubMed ID: 34948029)
21. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.
Wang Y; Chang J; Liu X; Zhang X; Zhang S; Zhang X; Zhou D; Zheng G
Aging (Albany NY); 2016 Nov; 8(11):2915-2926. PubMed ID: 27913811
[TBL] [Abstract][Full Text] [Related]
22. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.
Tarantini S; Balasubramanian P; Delfavero J; Csipo T; Yabluchanskiy A; Kiss T; Nyúl-Tóth Á; Mukli P; Toth P; Ahire C; Ungvari A; Benyo Z; Csiszar A; Ungvari Z
Geroscience; 2021 Oct; 43(5):2427-2440. PubMed ID: 34427858
[TBL] [Abstract][Full Text] [Related]
23. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
[TBL] [Abstract][Full Text] [Related]
24. A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells.
Escriche-Navarro B; Garrido E; Sancenón F; García-Fernández A; Martínez-Máñez R
Acta Biomater; 2024 Mar; 176():405-416. PubMed ID: 38185231
[TBL] [Abstract][Full Text] [Related]
25. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein.
Yang IH; Jung JY; Kim SH; Yoo ES; Cho NP; Lee H; Lee JY; Hong SD; Shin JA; Cho SD
Cell Oncol (Dordr); 2019 Jun; 42(3):357-368. PubMed ID: 30919222
[TBL] [Abstract][Full Text] [Related]
26. Senescence-associated β-galactosidase in subcutaneous adipose tissue associates with altered glycaemic status and truncal fat in severe obesity.
Rouault C; Marcelin G; Adriouch S; Rose C; Genser L; Ambrosini M; Bichet JC; Zhang Y; Marquet F; Aron-Wisnewsky J; Poitou C; André S; Dérumeaux G; Guerre-Millo M; Clément K
Diabetologia; 2021 Jan; 64(1):240-254. PubMed ID: 33125520
[TBL] [Abstract][Full Text] [Related]
27. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
[TBL] [Abstract][Full Text] [Related]
28. Controlled induction and targeted elimination of p16
Sessions GA; Copp ME; Liu JY; Sinkler MA; D'Costa S; Diekman BO
FASEB J; 2019 Nov; 33(11):12364-12373. PubMed ID: 31408372
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of intrinsic ageing of the skin via elimination of senescent dermal fibroblasts with senolytic drugs.
Kim H; Jang J; Song MJ; Kim G; Park CH; Lee DH; Lee SH; Chung JH
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1125-1135. PubMed ID: 35274377
[TBL] [Abstract][Full Text] [Related]
30. Identification of SYK inhibitor, R406 as a novel senolytic agent.
Cho HJ; Yang EJ; Park JT; Kim JR; Kim EC; Jung KJ; Park SC; Lee YS
Aging (Albany NY); 2020 May; 12(9):8221-8240. PubMed ID: 32379705
[TBL] [Abstract][Full Text] [Related]
31. ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.
Li J; Chen Y; Wan J; Liu X; Yu C; Li W
Br J Pharmacol; 2014 Jul; 171(13):3182-95. PubMed ID: 24571452
[TBL] [Abstract][Full Text] [Related]
32. p62/sequestosome-1 up-regulation promotes ABT-263-induced caspase-8 aggregation/activation on the autophagosome.
Huang S; Okamoto K; Yu C; Sinicrope FA
J Biol Chem; 2013 Nov; 288(47):33654-33666. PubMed ID: 24121507
[TBL] [Abstract][Full Text] [Related]
33. Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells.
Lafontaine J; Cardin GB; Malaquin N; Boisvert JS; Rodier F; Wong P
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494434
[TBL] [Abstract][Full Text] [Related]
34. Effects of triggers of senescence and senolysis in murine pancreatic cancer cells.
Revskij D; Woitas A; Kölle B; Umstätter C; Zechner D; Khan FM; Fuellen G; Jaster R
Hepatobiliary Pancreat Dis Int; 2024 Jun; ():. PubMed ID: 38879414
[TBL] [Abstract][Full Text] [Related]
35. One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.
Qing Y; Li H; Zhao Y; Hu P; Wang X; Yu X; Zhu M; Wang H; Wang Z; Guo Q; Hui H
Oxid Med Cell Longev; 2021; 2021():5529518. PubMed ID: 34603598
[TBL] [Abstract][Full Text] [Related]
36. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
Chang J; Wang Y; Shao L; Laberge RM; Demaria M; Campisi J; Janakiraman K; Sharpless NE; Ding S; Feng W; Luo Y; Wang X; Aykin-Burns N; Krager K; Ponnappan U; Hauer-Jensen M; Meng A; Zhou D
Nat Med; 2016 Jan; 22(1):78-83. PubMed ID: 26657143
[TBL] [Abstract][Full Text] [Related]
37. Death-seq identifies regulators of cell death and senolytic therapies.
Colville A; Liu JY; Rodriguez-Mateo C; Thomas S; Ishak HD; Zhou R; Klein JDD; Morgens DW; Goshayeshi A; Salvi JS; Yao D; Spees K; Dixon SJ; Liu C; Rhee JW; Lai C; Wu JC; Bassik MC; Rando TA
Cell Metab; 2023 Oct; 35(10):1814-1829.e6. PubMed ID: 37699398
[TBL] [Abstract][Full Text] [Related]
38. Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263.
Shao H; Jing K; Mahmoud E; Huang H; Fang X; Yu C
Mol Cancer Ther; 2013 Dec; 12(12):2640-50. PubMed ID: 24126433
[TBL] [Abstract][Full Text] [Related]
39. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).
Lam LT; Lu X; Zhang H; Lesniewski R; Rosenberg S; Semizarov D
Mol Cancer Ther; 2010 Nov; 9(11):2943-50. PubMed ID: 20829195
[TBL] [Abstract][Full Text] [Related]
40. The BH3 mimetic ABT-737 induces cancer cell senescence.
Song JH; Kandasamy K; Zemskova M; Lin YW; Kraft AS
Cancer Res; 2011 Jan; 71(2):506-15. PubMed ID: 21084274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
